M&A Deal Summary

Sun Pharmaceutical Industries Acquires Able Laboratories

On December 23, 2005, Sun Pharmaceutical Industries acquired medical products company Able Laboratories for 23M USD

Acquisition Highlights
  • This is Sun Pharmaceutical Industries’ 1st transaction in the Medical Products sector.
  • This is Sun Pharmaceutical Industries’ 2nd largest (disclosed) transaction.
  • This is Sun Pharmaceutical Industries’ 1st transaction in the United States.
  • This is Sun Pharmaceutical Industries’ 1st transaction in New Jersey.

M&A Deal Summary
Date 2005-12-23
Target Able Laboratories
Sector Medical Products
Buyer(s) Sun Pharmaceutical Industries
Deal Type Add-on Acquisition
Deal Value 23M USD

Target

Able Laboratories

Cranbury, New Jersey, United States
Able Laboratories is a developer and manufacturer of generic pharmaceutical products in tablet, capsule, liquid and suppository dosage forms

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Sun Pharmaceutical Industries

Cranbury, New Jersey, United States
Category Company
Founded 2004
Sector Medical Products
DESCRIPTION

Sun Pharmaceutical Industries, Inc. manufactures and distributes Medical prodicts.

DEAL STATS #
Overall 1 of 3
Sector (Medical Products) 1 of 2
Type (Add-on Acquisition) 1 of 2
State (New Jersey) 1 of 1
Country (United States) 1 of 2
Year (2005) 1 of 1
Size (of disclosed) 2 of 2
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2008-11-25 Chattem Chemicals

Chattanooga, Tennessee, United States

Chattem Chemicals, Inc. manufactures a variety of active pharmaceutical ingredients (APIs) and performance chemicals used in consumer and industrial markets.

Buy -
Mergr

Product

Company

Legal